Allosteric Loss-of-function Mutations in HIV-1 Nef from a Long-term Non-progressor

Journal of Molecular Biology

Volumn 374, Issue 1, 2007, Pages 121-129

  Trible, Ronald P ^a   Emert Sedlak, Lori ^a   Wales, Thomas E ^b   Ayyavoo, Velpandi ^c   Engen, John R ^b   Smithgall, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hck; HIV 1; Nef; SH3 domain; Src family kinase

Indexed keywords

HEMATOPOIETIC CELL KINASE; NEF PROTEIN; PROTEIN SH3; PROTEIN TYROSINE KINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLOSTERISM; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; DISEASE COURSE; ENZYME ACTIVATION; FEMALE; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; SEQUENCE ALIGNMENT; TARGET CELL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35348957280     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.09.009     Document Type: Article

References (40)

1. Fackler O.T., and Baur A.S. Live and let die: Nef functions beyond HIV replication. Immunity 16 (2002) 493-497
2. Greenway A.L., Holloway G., and McPhee D.A. HIV-1 Nef: a critical factor in viral-induced pathogenesis. Adv. Pharmacol. 48 (2000) 299-343
3. Hanna Z., Priceputu E., Kay D.G., Poudrier J., Chrobak P., and Jolicoeur P. In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice. Virology 327 (2004) 273-286
4. Joseph A.M., Kumar M., and Mitra D. Nef: "necessary and enforcing factor" in HIV infection. Curr. HIV Res. 3 (2005) 87-94
5. Kestler III H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 (1991) 651-662
6. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Absence of intact nef sequences in a long-term survivor with non-progressive HIV-1 infection. New Engl. J. Med. 332 (1995) 228-232
7. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270 (1995) 988-991
8. Mariani R., Kirchhoff F., Greenough T.C., Sullivan J.L., Desrosiers R.C., and Skowronski J. High frequency of defective nef alleles in a long-term survivor with non-progressive human immunodeficiency virus type 1 infection. J. Virol. 70 (1996) 7752-7764
9. Hanna Z., Kay D.G., Rebai N., Guimond A., Jothy S., and Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95 (1998) 163-175
10. Kim M.O., Suh H.S., Si Q., Terman B.I., and Lee S.C. Anti-CD45RO suppresses human immunodeficiency virus type 1 replication in microglia: role of Hck tyrosine kinase and implications for AIDS dementia. J. Virol. 80 (2006) 62-72
11. Komuro I., Yokota Y., Yasuda S., Iwamoto A., and Kagawa K.S. CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection. J. Exp. Med. 198 (2003) 443-453
12. Hanna Z., Weng X., Kay D.G., Poudrier J., Lowell C., and Jolicoeur P. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J. Virol. 75 (2001) 9378-9392
13. Briggs S.D., Sharkey M., Stevenson M., and Smithgall T.E. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272 (1997) 17899-17902
14. Lerner E.C., and Smithgall T.E. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo. Nature Struct. Biol. 9 (2002) 365-369
15. Choi H.J., and Smithgall T.E. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. J. Mol. Biol. 343 (2004) 1255-1268
16. Trible R.P., Emert-Sedlak L., and Smithgall T.E. HIV-1 Nef selectively activates SRC family kinases HCK, LYN, and c-SRC through direct SH3 domain interaction. J. Biol. Chem. 281 (2006) 27029-27038
17. Grzesiek S., Bax A., Clore G.M., Gronenborn A.M., Hu J.S., Kaufman J., et al. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Struct. Biol. 3 (1996) 340-345
18. Lee C.H., Saksela K., Mirza U.A., Chait B.T., and Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85 (1996) 931-942
19. Moarefi I., LaFevre-Bernt M., Sicheri F., Huse M., Lee C.H., Kuriyan J., and Miller W.T. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385 (1997) 650-653
20. Brugge J.S., Jarosik G., Andersen J., Queral-Lustig A., Fedor-Chaiken M., and Broach J.R. Expression of Rous sarcoma virus transforming protein pp60v-src in Saccharomyces cerevisiae cells. Mol. Cell Biol. 7 (1987) 2180-2187
21. Kornbluth S., Jove R., and Hanafusa H. Characterization of avian and viral p60src proteins expressed in yeast. Proc. Natl Acad. Sci. USA 84 (1987) 4455-4459
22. Schindler T., Sicheri F., Pico A., Gazit A., Levitzki A., and Kuriyan J. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3 (1999) 639-648
23. Porter M., Schindler T., Kuriyan J., and Miller W.T. Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand. J. Biol. Chem. 275 (2000) 2721-2726
24. Saksela K., Cheng G., and Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14 (1995) 484-491
25. Engen J.R., Smithgall T.E., Gmeiner W.H., and Smith D.L. Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry. Biochemistry 36 (1997) 14384-14391
26. Gmeiner W.H., Xu I., Horita D.A., Smithgall T.E., Engen J.R., Smith D.L., and Byrd R.A. Intramolecular binding of a proximal PPII helix to an SH3 domain in the fusion protein SH3Hck: PPIIhGAP. Cell Biochem. Biophys. 35 (2001) 115-126
27. Hochrein J.M., Lerner E.C., Schiavone A.P., Smithgall T.E., and Engen J.R. An examination of dynamics crosstalk between SH2 and SH3 domains by hydrogen/deuterium exchange and mass spectrometry. Protein Sci. 15 (2006) 65-73
28. Wales T.E., and Engen J.R. Partial unfolding of diverse SH3 domains on a wide timescale. J. Mol. Biol. 357 (2006) 1592-1604
29. Groesch T.D., and Freire E. Characterization of intramolecular interactions of HIV-1 accessory protein Nef by differential scanning calorimetry. Biophys. Chem. 126 (2007) 36-42
30. Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G., and Trono D. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nature Cell Biol. 2 (2000) 163-167
31. Blagoveshchenskaya A.D., Thomas L., Feliciangeli S.F., Hung C.H., and Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111 (2002) 853-866
32. Geyer M., and Peterlin B.M. Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Letters 496 (2001) 91-95
33. O'Neill E., Kuo L.S., Krisko J.F., Tomchick D.R., Garcia J.V., and Foster J.L. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor. Nef. J. Virol. 80 (2006) 1311-1320
34. Arold S.T., and Bauer A.S. Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem. Sci. 26 (2001) 356-363
35. Majumder B., Gray B., McBurney S., Schaefer T.M., Dentchev T., Mahalingam S., et al. Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine. Immunol. Letters 89 (2003) 207-214
36. Kushnirov V.V. Rapid and reliable protein extraction from yeast. Yeast 16 (2000) 857-860
37. Hochrein J.M., Wales T.E., Lerner E.C., Schiavone A.P., Smithgall T.E., and Engen J.R. Conformational features of the full-length HIV and SIV Nef proteins determined by mass spectrometry. Biochemistry 45 (2006) 7733-7739
38. Lee C.H., Leung B., Lemmon M.A., Zheng J., Cowburn D., Kuriyan J., and Saksela K. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14 (1995) 5006-5015
39. Zhang Z., and Smith D.L. Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 2 (1993) 522-531
40. Wales T.E., and Engen J.R. Hydrogen exchange mass spectrometry for the analysis of protein dynamics. Mass Spectrom. Rev. 25 (2006) 158-170